Background Serotonin reuptake inhibitor (SRI) antidepressants are implicated in increasing
the risk of bleeding among users; however, the comparative increase in bleeding risk with …

Objective: This nonsystematic review describes risk of bleeding in treatment with serotonin
reuptake inhibitors (SRIs) and provide recommendations for the management of patients at …

Selective serotonin reuptake inhibitors (SSRIs) have been reported to be potentially
associated with an increased risk of bleeding. A meta-analysis of observational studies was …

WHAT IS ALREADY KNOWN ABOUT THIS SUBJECT• Selective serotonin re‐uptake
inhibitors (SSRI) are associated with an increased risk of bleeding disorders at a number of …

Importance Selective serotonin reuptake inhibitors (SSRIs) are commonly prescribed
antidepressants associated with a small increased risk of major bleeding. However, the risk …

PURPOSE: Selective serotonin reuptake inhibitors (SSRIs) are first line agents to treat
clinical depression. Although these medications exhibit a favorable safety profile, there are …

Background: It is generally believed that selective serotonin reuptake inhibitor (SSRI) drugs
increase the risk of abnormal bleeding and decrease the risk of ischemic heart disease …

Background and Purpose—Selective serotonin reuptake inhibitors (SSRI) are widely
prescribed. Several reports have observed an increased bleeding risk associated with SSRI …

Selective serotonin reuptake inhibitors (SSRIs) are among the most commonly prescribed
medications in the United States. Although SSRIs are highly tolerable relative to other …

Objective: We synthesized the epidemiologic evidence concerning selective serotonin
reuptake inhibitor (SSRI) exposure and the risk of CNS hemorrhage. Methods: We searched …